Jan. 15, 2025 — Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. ... New Innovative Local Treatment ...

Aragen Life Sciences secured a $100 million investment from Quadria Capital, selling a 10% stake at a $1.4 billion valuation.

Unlike first-generation entrepreneurs, Parvinder inherited Ranbaxy—a modest pharma business his father, Bhai Mohan Singh, had acquired from its founders, Ranbir Singh and Gurbax Singh. A wealthy ...

The hefty tariffs President-elect Trump has pledged to levy on U.S. imports could impact the price and availability of pharmaceutical drugs. Trump has floated 25 percent tariffs on imports from ...

He has previously worked with Cadila Healthcare and Ranbaxy Laboratories, and is now the COO of Inventia Healthcare. Manjula Devi Shroff is a Non-Executive, Independent Director with over 15 years ...

Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company")(LSE:HEMO) is pleased to announce the opening of the first clinical site for its lead asset, HG-CT-1, targeting relapsed ...

STOCKHOLM & RADNOR, Pa., December 30, 2024--(BUSINESS WIRE)--Immedica Pharma AB (Immedica), a leading global rare disease company, and Marinus Pharmaceuticals, Inc ...

Senores Pharmaceuticals IPO Allotment Today: At the upper price band, the company is valued at a P/E of 55x with a market cap of Rs 1800.6 crore (Image: Freepik) The company’s shares were ...